NCT06356389View on ClinicalTrials.gov

A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

December 27, 2022

Study Completion Date

January 28, 2023

Conditions
Schizophrenia
Interventions
DRUG

JX11502MA

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (1)

201109

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
collaborator

Shanghai Mental Health Center

OTHER

lead

Zhejiang Jingxin Pharmaceutical Co., Ltd.

INDUSTRY